Precision Neuroscience reported recording cortical electrical activity through 4,096 electrodes during a 2024 procedure at Mount Sinai. The temporary array sampled signals from the brain’s surface; the milestone does not mean the system can freely read a person’s thoughts or is available as a consumer device.
What happened in the 4,096-electrode procedure?
In April 2024, surgeons at Mount Sinai Health System in New York temporarily placed four of Precision Neuroscience’s Layer 7 films on a patient’s cortical surface during a clinical-study procedure. Each thin-film array contains 1,024 miniature electrodes and covers about 1.6 square centimeters; the four films together covered roughly 8 square centimeters. Precision described the procedure as a world record for electrodes placed on and recording cortical data from a human brain.
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
Brain-Computer Interface Technologies: Accelerating Neuro-Technology for Human Benefit | $93.01 | Buy on Amazon |
| 2 |
|
Brain Computer Interface | $47.24 | Buy on Amazon |
| 3 |
|
Brain Computer Interface | $2.99 | Buy on Amazon |
| 4 |
|
Brain-Computer Interfacing: An Introduction | $44.99 | Buy on Amazon |
Precision said Mount Sinai’s research was conducted by independent investigators without financial ties to the company. The record claim and device details were reported by Precision and contemporaneous trade coverage; the claim should therefore be understood as the company’s description of the milestone, not as a universal ranking of every neural-recording system.
Does “read brainwaves” mean it can read thoughts?
No. In this context, “read” means recording electrical activity from the brain’s cortex for brain-computer-interface research. The electrode count describes how many recording sites the array offers, not how accurately it can interpret a person’s thoughts.
#1 Best Overall
More electrodes can provide denser spatial sampling and more neural data channels. But count alone does not establish what a decoder can infer, how reliably it can do so, whether the system is safe over the long term, or whether it offers a clinical benefit. Those are separate questions that require suitable clinical and peer-reviewed outcome evidence. Precision reported real-time decoding of intended movement in its September 2026 company announcement; that is a specific capability claim, not evidence of unrestricted mind reading.
How does Precision’s system compare with other 4,096-channel claims?
Several distinct projects use a 4,096 figure, but they do not describe interchangeable devices or the same kind of experiment.
Rank #2
| Program | Setting and placement | What the reported count means | Reported evidence and status |
|---|---|---|---|
| Precision Neuroscience Layer 7 | Temporary placement on a living human’s cortical surface during a Mount Sinai clinical-study procedure in April 2024. | 4,096 electrodes across four films; each film has 1,024 electrodes. | Precision reported human cortical recording in that procedure. In September 2026, the company reported FDA clearance, procedures at more than 100 patients across 18 institutions, and real-time decoding of intended movement. The announcement does not specify the clearance’s scope in the information reported here. |
| Harvard SEAS silicon chip | Laboratory recording from cultured rat neurons, not a human cortical procedure. | A 4,096-microhole-electrode silicon chip for intracellular recording. | Harvard SEAS reported that more than 3,600 electrodes coupled intracellularly on average and that the team identified over 70,000 plausible synaptic connections from about 2,000 neurons. These are results from a separate in-vitro experiment, not from Precision’s system. |
| UC San Diego PtNRGrid | A separate cortical-grid research program; the university described work toward a clinical trial and eventual commercial use. | The research group reported increasing its grid to 4,096 channels. | UC San Diego said the program obtained FDA authorization for a clinical trial. This is a different technology and development path from Precision’s Layer 7. |
The comparison shows why the number is not a stand-alone measure of performance: the projects differ in preparation (human versus cultured animal neurons), recording approach, clinical stage, and what their reported count represents. A larger count by itself does not establish better decoding or greater clinical usefulness.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What is Precision Neuroscience’s status now?
As of the company’s September 2026 announcement, Precision said Layer 7 had FDA clearance and that its clinical network had conducted procedures involving more than 100 patients at 18 institutions. It also reported high-resolution neural recording across the full array and a partnership with Medtronic to integrate the technology with a neurosurgical platform. These are company-reported milestones; the announcement also describes continued clinical and commercialization work.
Rank #3
That announcement does not establish unrestricted consumer availability. Layer 7 and compatible arrays are clinical or research equipment, not ordinary consumer brain-computer interfaces. A generic EEG headset is not an equivalent product: it records scalp electrical signals rather than using a temporarily placed cortical surface array.
Precision also announced a $250 million Series D in September 2026, co-led by Pershing Square Inc., the Ackman Oxman Institute, and a life-sciences investment fund. The financing is a company milestone, not evidence by itself of device performance or patient benefit.
Quick Recap
Rank #4
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
